Michael R. Dury, CEO of Merchants Capital at Merchants Bancorp (NASDAQ:MBIN), filed a Form 4 on November 6, 2026, disclosing a disposition of 9,500 shares of common stock on November 5, 2026, via a gift transaction at $0.00.
Guardforce AI Co., Limited filed a Form 6-K with the SEC on November 6, 2026, reporting the voting results from its adjourned extraordinary general meeting held on November 3, 2026, at which shareholders approved all three proposals including a capital reorganization, a dual-class share …
Daniel Bernstein, a director and 10% owner of Bel Fuse Inc /NJ, filed a statement of changes in beneficial ownership on November 6, 2026, reporting a gift of 138 shares of Class B Common Stock on November 4, 2026.
Bitwise 10 Crypto Index ETF (NYSE Arca: BITW) filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 6, 2026, covering the fiscal quarter ended September 30, 2026.
Skyward Specialty Insurance Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter net income of $49.8 million and total assets of $7.1 billion.
Ares Management Corporation filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter ended September 30, 2026.
Director David D. Meek filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 9,080 ordinary shares of uniQure N.V. on NASDAQ under a pre-established 10b5-1 trading plan.
SharkNinja, Inc. officer Neil Shah filed a Form 144 notice of proposed sale on November 6, 2026, covering 50,000 ordinary shares to be sold on behalf of Shah Family Partners LP on the NYSE.
Allstate Corp officer and director Thomas J. Wilson filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 43,077 shares of Allstate common stock through Fidelity Brokerage Services LLC on NYSE.
Barclays PLC filed Amendment No. 1 to a Schedule 13G with the SEC on November 6, 2026, disclosing a beneficial ownership position in the common stock of Cartesian Therapeutics Inc as of September 30, 2026.